In vitro effect of retinoic acid and epigenetic modifying drugs on mesenchymal stem cells

Effetto in vitro dell'acido retinoico e dei farmaci epigenetici sulle cellule staminali mesenchimali

[1]  L. Altucci,et al.  Histone deacetylase inhibitors promote apoptosis and senescence in human mesenchymal stem cells. , 2009, Stem Cells and Development.

[2]  Yvonne Tay,et al.  MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation , 2008, Nature.

[3]  C. Jorgensen,et al.  Concise Review: Adult Multipotent Stromal Cells and Cancer: Risk or Benefit? , 2008, Stem cells.

[4]  G. Daley,et al.  Molecular basis of pluripotency. , 2008, Human molecular genetics.

[5]  Y. Loh,et al.  Molecular framework underlying pluripotency , 2008, Cell cycle.

[6]  A. Caplan.  Adult mesenchymal stem cells for tissue engineering versus regenerative medicine , 2007, Journal of cellular physiology.

[7]  B. Sacchetti,et al.  Self-Renewing Osteoprogenitors in Bone Marrow Sinusoids Can Organize a Hematopoietic Microenvironment , 2007, Cell.

[8]  L. Altucci,et al.  RAR and RXR modulation in cancer and metabolic disease , 2007, Nature Reviews Drug Discovery.

[9]  Jorge Cortes,et al.  Safety and clinical activity of the combination of 5-azacytidine, valproic acid, and all-trans retinoic acid in acute myeloid leukemia and myelodysplastic syndrome. , 2007, Blood.

[10]  A. Hollander,et al.  Pharmacological Regulation of Adult Stem Cells: Chondrogenesis Can Be Induced Using a Synthetic Inhibitor of the Retinoic Acid Receptor , 2007 .

[11]  Matthew D. Kwan,et al.  Refining retinoic acid stimulation for osteogenic differentiation of murine adipose-derived adult stromal cells. , 2007, Tissue engineering.

[12]  H. Gronemeyer,et al.  Structure, function and modulation of retinoic acid receptor beta, a tumor suppressor. , 2007, The international journal of biochemistry & cell biology.

[13]  S. Morrison,et al.  Maintaining hematopoietic stem cells in the vascular niche. , 2006, Immunity.

[14]  G. Eichele,et al.  International Union of Pharmacology. LX. Retinoic Acid Receptors , 2006, Pharmacological Reviews.

[15]  Stuart H. Orkin,et al.  A protein interaction network for pluripotency of embryonic stem cells , 2006, Nature.

[16]  Hanns-Ulrich Marschall,et al.  Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease , 2006, Transplantation.

[17]  P. Chambon,et al.  RARγ is critical for maintaining a balance between hematopoietic stem cell self-renewal and differentiation , 2006, The Journal of experimental medicine.

[18]  Megan F. Cole,et al.  Control of Developmental Regulators by Polycomb in Human Embryonic Stem Cells , 2006, Cell.

[19]  X. Chen,et al.  The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells , 2006, Nature Genetics.

[20]  U. Hacksell,et al.  Identification of novel subtype selective RAR agonists. , 2005, Biochemical pharmacology.

[21]  Hyunjin Cho,et al.  Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors , 2005, Journal of cellular biochemistry.

[22]  Megan F. Cole,et al.  Core Transcriptional Regulatory Circuitry in Human Embryonic Stem Cells , 2005, Cell.

[23]  Michael G. Rosenfeld,et al.  Controlling nuclear receptors: the circular logic of cofactor cycles , 2005, Nature Reviews Molecular Cell Biology.

[24]  V. Goldberg,et al.  Repair of osteochondral defects with hyaluronan- and polyester-based scaffolds. , 2005, Osteoarthritis and cartilage.

[25]  S. Lippman,et al.  Increased Retinoic Acid Receptor-β4 Correlates In vivo with Reduced Retinoic Acid Receptor-β2 in Esophageal Squamous Cell Carcinoma , 2005, Cancer Epidemiology Biomarkers & Prevention.

[26]  R. Krumlauf,et al.  Direct crossregulation between retinoic acid receptor β and Hox genes during hindbrain segmentation , 2005, Development.

[27]  Xiran Zhang,et al.  Mesenchymal Stern Cells from Adult Human Bone Marrow Differentiate into a Cardiomyocyte Phenotype In Vitro , 2004, Experimental biology and medicine.

[28]  F. Della Ragione,et al.  Retinoic acid inhibits the growth of bone marrow mesenchymal stem cells and induces p27Kip1 and p16INK4A up-regulation , 2003, Molecular and Cellular Biochemistry.

[29]  I. Sekiya,et al.  Expansion of Human Adult Stem Cells from Bone Marrow Stroma: Conditions that Maximize the Yields of Early Progenitors and Evaluate Their Quality , 2002, Stem cells.

[30]  R. Pili,et al.  Endogenous reactivation of the RARbeta2 tumor suppressor gene epigenetically silenced in breast cancer. , 2002, Cancer research.

[31]  S. Minucci,et al.  Methyltransferase Recruitment and DNA Hypermethylation of Target Promoters by an Oncogenic Transcription Factor , 2002, Science.

[32]  H. Niwa,et al.  Molecular mechanism to maintain stem cell renewal of ES cells. , 2001, Cell structure and function.

[33]  A. Meunier,et al.  Tissue-engineered bone regeneration , 2000, Nature Biotechnology.

[34]  V. Giguère,et al.  RARβ mediates the response of Hoxd4 and Hoxb4 to exogenous retinoic acid , 1999, Developmental dynamics : an official publication of the American Association of Anatomists.

[35]  Y. Hashimoto,et al.  Identification of a Novel Class of Retinoic Acid Receptor β-Selective Retinoid Antagonists and Their Inhibitory Effects on AP-1 Activity and Retinoic Acid-induced Apoptosis in Human Breast Cancer Cells* , 1999, The Journal of Biological Chemistry.

[36]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[37]  D. Benayahu,et al.  Single‐Colony Derived Strains of Human Marrow Stromal Fibroblasts Form Bone After Transplantation In Vivo , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[38]  S. Schreiber,et al.  Nuclear Receptor Repression Mediated by a Complex Containing SMRT, mSin3A, and Histone Deacetylase , 1997, Cell.

[39]  P. Chambon.  A decade of molecular biology of retinoic acid receptors , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[40]  S. Gronthos,et al.  The STRO-1+ fraction of adult human bone marrow contains the osteogenic precursors. , 1994, Blood.

[41]  A. V. van Puijenbroek,et al.  Characterization of a negative retinoic acid response element in the murine Oct4 promoter , 1994, Molecular and cellular biology.

[42]  P. Martiat,et al.  Poor response to all-trans retinoic acid therapy in a t(11;17) PLZF/RAR alpha patient. , 1994, Leukemia.

[43]  P. Chambon,et al.  RAR-beta 4, a retinoic acid receptor isoform is generated from RAR-beta 2 by alternative splicing and usage of a CUG initiator codon. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[44]  H. de Thé,et al.  All-trans retinoic acid modulates the retinoic acid receptor-alpha in promyelocytic cells. , 1991, The Journal of clinical investigation.

[45]  H. Hamada,et al.  The oct3 gene, a gene for an embryonic transcription factor, is controlled by a retinoic acid repressible enhancer. , 1991, The EMBO journal.

[46]  R. Berger,et al.  RETINOIC ACID THERAPY FOR PROMYELOCYTIC LEUKAEMIA , 1989, The Lancet.

[47]  A. Friedenstein,et al.  Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers , 1987, Cell and tissue kinetics.

[48]  A. Friedenstein,et al.  Osteogenesis in transplants of bone marrow cells. , 1966, Journal of embryology and experimental morphology.

[49]  M. Kassem,et al.  Human mesenchymal stem cells: from basic biology to clinical applications , 2008, Gene Therapy.

[50]  D. Soprano,et al.  Role of retinoic acid in the differentiation of embryonal carcinoma and embryonic stem cells. , 2007, Vitamins and hormones.

[51]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[52]  Kevin McIntosh,et al.  Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. , 2002, Experimental hematology.

[53]  P G Pelicci,et al.  Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia. , 2001, Cancer research.

[54]  M. Privalsky.  Regulation of SMRT and N-CoR corepressor function. , 2001, Current topics in microbiology and immunology.

[55]  A. Friedenstein,et al.  OSTEOGENIC STEM CELLS IN BONE MARROW , 1990 .